Charles Kunos

Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator.

Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.

Intraoperative electron radiotherapy for extremity sarcomas does not increase acute or late morbidity.

Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study.

Comparison of helical tomotherapy versus conventional radiation to deliver craniospinal radiation.

Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy.

Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma.

Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged >/=55 Years in the SEER-Medicare Population.

Radiation therapy in addition to gross total resection of retroperitoneal sarcoma results in prolonged survival: results from a single institutional study.

Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial.

Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies.

Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group study.

Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.

Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.

Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer.

Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study.

Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer.

Ribonucleotide Reductase Inhibition Enhances Chemoradiosensitivity of Human Cervical Cancers.

Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers.

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.

Low-dose-rate brachytherapy for treatment of uterine didelphys malignancy.

Radiosensitization of human cervical cancer cells by inhibiting ribonucleotide reductase: enhanced radiation response at low-dose rates.

Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers.

18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.

Emerging application of stereotactic body radiation therapy for gynecologic malignancies.

Chemotherapy plus radiation in advanced-stage endometrial cancer.

Stereotactic body radiation therapy for nonresectable tumors of the pancreas.

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.

Robotic surgery in gynecologic oncology.

On model ensemble analyses of nonmonotonic data.

Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia.